Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk status

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk status'. Together they form a unique fingerprint.

Medicine & Life Sciences